AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹120 Cr | ₹102 Cr | ₹103 Cr | ₹105 Cr | ₹129 Cr |
What is the latest Total Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹102 Cr |
| Mar2023 | ₹103 Cr |
| Mar2022 | ₹105 Cr |
| Mar2021 | ₹129 Cr |
How is Total Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 17.68 | |
| Mar2024 | ₹102 Cr | -0.54 | |
| Mar2023 | ₹103 Cr | -2.46 | |
| Mar2022 | ₹105 Cr | -17.95 | |
| Mar2021 | ₹129 Cr | - | |
Compare Total Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹242.1 Cr | -4.8% | -2.9% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.8% |
-2.9% |
-11.9% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses